Semisynthetic bile acids: a new therapeutic option for metabolic syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Semisynthetic bile acids: a new therapeutic option for metabolic syndrome

Published:2019-08 Issue: Volume:146 Page:104333
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Lazarević Slavica,Đanić Maja,Goločorbin-Kon Svetlana,Al-Salami Hani,Mikov Momir

Funder

Project of Ministry of Education, Science and Technological Development, Republic of Serbia

Project for Scientific and Technological Development of Vojvodina

Horizon2020 MEDLEM project

Publisher

Elsevier BV

Subject

Pharmacology

Reference146 articles.

1. Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease;Machado;Cell Death Dis.,2017

2. A fresh look at NASH pathogenesis. Part 1: the metabolic movers;Larter;J. Gastroenterol. Hepatol.,2010

3. From the metabolic syndrome to NAFLD or vice versa?;Vanni;Dig. Liver Dis.,2010

4. Human fatty liver disease: old questions and new insights;Cohen;Science.,2011

5. Type 1 diabetes, metabolic syndrome and cardiovascular risk;Chillaron;Metabolism,2014

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corrigendum to “Changes of bacterial communities and bile acid metabolism reveal the potential ‘intestine-hepatopancreas axis’ in shrimp” [Sci. Total Environ. 938 (2024) 173384];Science of The Total Environment;2024-09

2. Changes of bacterial communities and bile acid metabolism reveal the potential “intestine-hepatopancreas axis” in shrimp;Science of The Total Environment;2024-08

3. Update on the development of TGR5 agonists for human diseases;European Journal of Medicinal Chemistry;2024-05

4. The gut-liver nexus: exploring gut microbiota dysbiosis in non-alcoholic fatty liver disease and its therapeutic implications;Egyptian Liver Journal;2024-04-25

5. The effect and safety of obeticholic acid for patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials;Medicine;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3